NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 8 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $752,000 | -19.5% | 1,378,939 | -14.2% | 0.00% | – |
Q2 2016 | $934,000 | -68.8% | 1,606,895 | -21.7% | 0.00% | – |
Q1 2016 | $2,997,000 | -48.5% | 2,053,389 | +13.0% | 0.00% | – |
Q4 2015 | $5,816,000 | -44.2% | 1,817,613 | +9.1% | 0.00% | – |
Q3 2015 | $10,415,000 | -34.4% | 1,666,407 | +4.2% | 0.00% | -100.0% |
Q2 2015 | $15,886,000 | +69.2% | 1,599,804 | +25.6% | 0.00% | 0.0% |
Q1 2015 | $9,387,000 | +43.9% | 1,273,607 | +4.5% | 0.00% | – |
Q4 2014 | $6,523,000 | +15.6% | 1,219,320 | +8.6% | 0.00% | – |
Q3 2014 | $5,645,000 | -13.8% | 1,122,434 | +15.0% | 0.00% | -100.0% |
Q2 2014 | $6,548,000 | +6.7% | 975,859 | +15.1% | 0.00% | 0.0% |
Q1 2014 | $6,136,000 | +128.2% | 847,628 | +18.8% | 0.00% | – |
Q4 2013 | $2,689,000 | +115.3% | 713,258 | +91.4% | 0.00% | – |
Q3 2013 | $1,249,000 | +0.9% | 372,691 | +0.6% | 0.00% | – |
Q2 2013 | $1,238,000 | – | 370,571 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 9,379,987 | $69,131,000 | 9.82% |
Family Management Corp | 82,875 | $611,000 | 0.28% |
Montecito Bank & Trust | 75,717 | $558,000 | 0.28% |
Bedell Frazier Investment Counselling, LLC | 62,825 | $463,000 | 0.19% |
Lyons Wealth Management, LLC. | 20,000 | $147,000 | 0.16% |
Price Capital Management, Inc. | 28,864 | $213,000 | 0.13% |
BOLTON LP | 50,000 | $369,000 | 0.10% |
BOLTON LP | 50,000 | $369,000 | 0.10% |
WEDBUSH SECURITIES INC | 76,500 | $564,000 | 0.10% |
HYMAN CHARLES D | 43,375 | $320,000 | 0.05% |